NewsBenzingaKazia Therapeutics Says Two Abstracts Highlighting Paxalisib Tumor And Immune Reprogramming Research Accepted For Poster Presentation At 2026 San Antonio Breast Cancer Symposium Kazia Therapeutics Says Two Abstracts Highlighting Paxalisib Tumor And Immune Reprogramming Research Accepted For Poster Presentation At 2026 San Antonio Breast Cancer Symposium Benzinga 2026.11.02 12:12 (GMT+0) Open on Benzinga Other news Strive Adds 124 BTC, Total Holdings Reach 43,124 BTC Wall Street Analysts Are Slashing Price Targets on Coinbase Stock. Here’s Why. Freeport-McMoRan Stock: Analyst Estimates & Ratings HSBC's HKD Stablecoin RedCoin Hits 50,000 Users in First Week, Circulation at HK$87.75 Million Binance: ZK Proof for Oct. 31 Reserve Snapshot Generated, Asset Replenishment Reaches 95% ZachXBT Flags Suspected $106 Million-Plus Theft From EU Entity
